Erectile dysfunction is one of the most common men's health conditions — affecting an estimated 30 million men in the United States — and one of the most undertreated. Many men experiencing ED either attribute it to stress or aging without seeking evaluation, or feel reluctant to discuss it with a provider.
The reality is that ED is a medical condition with identifiable clinical causes and effective evidence-based treatments. Understanding what causes erectile dysfunction — and why it matters beyond sexual health — is the first step toward appropriate clinical evaluation and individualized care.
Clinical note: This article is for educational purposes. Erectile dysfunction should be evaluated by a licensed provider to identify contributing causes and guide individualized treatment. Learn about SEVEN's ED treatment program →
Erectile dysfunction is defined clinically as the consistent or recurrent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. The key word is "consistent" — occasional difficulty achieving erection is common and not necessarily indicative of erectile dysfunction. ED is characterized by a persistent pattern that interferes with sexual function.
ED occurs across a wide age range. While prevalence increases with age — affecting approximately 40% of men at age 40 and 70% of men at age 70 — it is not simply an aging phenomenon. Younger men are increasingly presenting with ED, and in many of these cases the underlying cause is metabolic or lifestyle-related rather than age-related vascular decline.
Understanding what causes ED requires first understanding how erections work physiologically.
An erection is a vascular event. Sexual arousal triggers neural signals that cause smooth muscle relaxation in the penile arteries and corpus cavernosum — the erectile tissue. This allows blood to flow in and become trapped, creating the pressure that produces erection. The endothelium — the inner lining of blood vessels — plays a critical role in this process by producing nitric oxide, which mediates smooth muscle relaxation.
Any factor that impairs this vascular mechanism — reduced blood flow, endothelial dysfunction, smooth muscle impairment, or disrupted neural signaling — can result in erectile dysfunction. This is why ED is so closely connected to cardiovascular and metabolic health.
The most prevalent underlying cause of erectile dysfunction is vascular — specifically, impaired blood flow to penile tissue due to the same atherosclerotic and endothelial dysfunction that affects cardiovascular health systemically.
Atherosclerosis — the buildup of plaque in arterial walls — reduces blood flow throughout the body. The penile arteries are smaller than the coronary arteries, which means they often show signs of atherosclerosis and reduced perfusion before cardiac symptoms become apparent. This is clinically significant: ED in men with no obvious cause is now considered a potential early marker of cardiovascular disease.
Current clinical guidelines recommend that men presenting with new-onset ED receive cardiovascular risk assessment, even in the absence of cardiac symptoms. In this sense, ED can be understood as a window into vascular health — a signal worth taking seriously beyond its immediate impact on sexual function.
High blood pressure damages endothelial cells over time, impairing their ability to produce nitric oxide — the signaling molecule that enables smooth muscle relaxation and blood flow during arousal. Hypertension is one of the most common medical conditions associated with ED, and the relationship is bidirectional: antihypertensive medications (particularly older classes) can also impair erectile function as a side effect.
Endothelial dysfunction — impaired function of the blood vessel lining — is a central mechanism in both cardiovascular disease and erectile dysfunction. It reduces nitric oxide bioavailability, increases vascular resistance, and impairs the local vascular response required for erection. Endothelial dysfunction is directly linked to metabolic dysfunction, obesity, insulin resistance, and chronic inflammation.
The relationship between metabolic health and erectile function is well established and mechanistically direct. Metabolic dysfunction impairs erectile function through multiple pathways simultaneously.
Diabetes — both type 1 and type 2 — is one of the strongest risk factors for erectile dysfunction. Men with diabetes are approximately three times more likely to experience ED than men without diabetes, and ED in diabetic men tends to occur at a younger age and be more severe.
The mechanisms are multiple: advanced glycation end-products damage blood vessels and nerves, hyperglycemia promotes endothelial dysfunction, autonomic neuropathy impairs the neural signaling required for arousal, and the metabolic milieu associated with insulin resistance promotes systemic vascular damage.
Obesity is strongly associated with erectile dysfunction — and the relationship is not simply correlational. Excess adiposity — particularly visceral fat — drives ED through several mechanisms:
Clinical studies have demonstrated that significant weight loss — particularly through interventions that address underlying metabolic dysfunction, including GLP-1 therapy — can produce meaningful improvements in erectile function. This is part of why SEVEN's approach to medical weight loss considers the full metabolic health picture, not just the number on the scale.
Testosterone plays a central role in male sexual health — including libido, arousal, and the maintenance of normal erectile tissue function. Testosterone deficiency is a recognized contributor to erectile dysfunction, though the relationship is more complex than is often assumed.
The signs of low testosterone extend well beyond sexual function, but sexual symptoms — including reduced libido and erectile difficulty — are among the most common presenting complaints in men with hypogonadism. Testosterone supports the sensitivity of erectile tissue to sexual stimulation and maintains the health of smooth muscle in the corpus cavernosum.
Importantly, low testosterone often coexists with vascular ED rather than causing it independently. Clinical evaluation is designed to identify the relative contributions of hormonal and vascular factors to guide individualized treatment decisions.
There is a well-documented bidirectional relationship between testosterone and metabolic health. Obesity reduces testosterone by increasing aromatase activity — converting testosterone to estrogen. Low testosterone, in turn, promotes fat accumulation and metabolic dysfunction — creating a reinforcing feedback loop.
This is why comprehensive men's health evaluation considers both hormonal and metabolic contributors simultaneously, rather than treating each in isolation.
Normal erectile function requires intact neural pathways — both the autonomic nervous system that controls smooth muscle relaxation and the somatic nervous system that mediates sensation. Neurological conditions that disrupt these pathways can cause or contribute to ED.
Common neurological causes include:
While the majority of ED in men over 40 has a significant organic (physical) component, psychological factors play a meaningful role in many cases — and often coexist with physical causes even when they are not the primary driver.
Performance anxiety creates a self-reinforcing cycle. An episode of ED — for any reason — can generate anxiety about future sexual performance. This anxiety activates the sympathetic nervous system and elevates cortisol, both of which actively inhibit the parasympathetic processes required for erection. The result is that psychological anxiety can produce or worsen physical ED, even when the original cause was situational.
Depression is independently associated with erectile dysfunction through both central nervous system effects on libido and arousal, and through the side effects of antidepressant medications — particularly SSRIs, which are among the most commonly prescribed drugs for depression and which frequently cause sexual dysfunction as an adverse effect.
Relationship conflict, stress, major life events, and situational factors can all contribute to ED — particularly in younger men where organic causes are less prevalent. A thorough clinical evaluation considers the psychological and relational context alongside physical contributing factors.
A substantial number of commonly prescribed medications are associated with erectile dysfunction as a side effect. Men who develop ED after starting a new medication should discuss this with their prescribing provider. Relevant medication classes include:
Never discontinue a prescribed medication without consulting your provider. If you suspect a medication is contributing to ED, clinical evaluation can help determine whether an alternative is appropriate.
One of the most important clinical insights about erectile dysfunction over the past two decades is its value as a marker of broader health. ED is not simply a sexual health issue — it is a vascular, metabolic, and hormonal health signal that reflects the underlying state of multiple physiological systems.
Men who develop ED — particularly at younger ages and without obvious contributing factors — benefit from comprehensive clinical evaluation that goes beyond sexual function. This evaluation may reveal early cardiovascular risk, metabolic dysfunction, hormonal imbalances, or other conditions that warrant clinical attention independent of the ED itself.
This is the lens through which SEVEN approaches ED treatment — as one component of comprehensive metabolic and men's health care, not as an isolated condition requiring a prescription.
SEVEN offers discreet, clinician-guided ED treatment online. No in-person visit required. All prescriptions are based on individual clinical evaluation. Join early access to be notified when enrollment opens.
Learn About ED Treatment →